1-20 of 182
ovarian cancer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pluripotent stem cell–derived NK cells with high-affinity noncleavable CD16a mediate improved antitumor activity

Huang Zhu, Robert H. Blum, Ryan Bjordahl, Svetlana Gaidarova, Paul Rogers, Tom Tong Lee, Ramzey Abujarour, Gregory B. Bonello, Jianming Wu, Pei-Fang Tsai, Jeffrey S. Miller, Bruce Walcheck, Bahram Valamehr, Dan S. Kaufman
Journal: Blood
Blood (2020) 135 (6): 399–410.
https://doi.org/10.1182/blood.2019000621
Published: 2020
Includes: Multimedia, Supplemental data
Journal Articles

Carbon Dots As a Potential Therapeutic Agent for Anemia Treatment in Malignancies

Yuanlin Xu, Boyang Wang, Huan Zhang, Xiaoli Qu, Mingming Zhang, Xiuli An, Siyu Lu, Shijie Zhang
Journal: Blood
Blood (2019) 134 (Supplement_1): 941.
https://doi.org/10.1182/blood-2019-130971
Published: 2019
Journal Articles

iPSC-Derived NK Cells Synergize with T Cells and Anti-PD-1 Antibody to Mediate Durable Anti-Tumor Responses In Vivo

Jeffrey S. Miller, MD, Ryan Bjordahl, PhD, Svetlana Gaidarova, MS, Sajid Mahmood, PhD, Paul Rogers, PhD, Ge Moyar, Bruce R. Blazar, MD, Dan S Kaufman, MD PhD, Bahram Valamehr, PhD, Frank Cichocki, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1933.
https://doi.org/10.1182/blood-2019-124961
Published: 2019
Journal Articles

Safety and Effectiveness of Rivaroxaban Versus Low Molecular Weight Heparin for Treatment of Cancer-Associated Venous Thrombosis: A SEER-Medicare-Linked Data Analysis

Christine G. Kohn, PharmD, Gary H. Lyman, MD MPH, Nicole M. Kuderer, Thomas J. Bunz, PharmD, PhD, Craig I. Coleman, PharmD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3673.
https://doi.org/10.1182/blood-2019-128581
Published: 2019
Journal Articles

Small Molecule Screening Identifies Rho-Associate Protein Kinase (ROCK) As a Regulator of NK Cell Cytotoxicity Against Cancer

Grace Lee, Sheela Karunanithi, Zachary Jackson, David Wald, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3607.
https://doi.org/10.1182/blood-2019-131947
Published: 2019
Journal Articles

Host and Tumor Factor XII Drive Ovarian Cancer Maintenance and Progression

Evi X Stavrou, MD, Kara L. Bane, M.Sc., Peronne Joseph, M.Sc., Anil Belur Nagaraj, PhD, Analisa Difeo, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2384.
https://doi.org/10.1182/blood-2019-125862
Published: 2019
Journal Articles

Targeting Misfolded p53 and p53 Aggregation to Overcome Resistance to Apoptosis in Acute Myeloid Leukemia

Michael Andreeff, MD PhD, Jianfang Zeng, MD, Alice Soragni, PhD, Vivian Ruvolo, Bing Z Carter, PhD, Jo Ishizawa, MD PhD, Jared K. Burks, PhD, David Eisenberg, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3786.
https://doi.org/10.1182/blood-2019-130900
Published: 2019
Journal Articles

DNA Methyltransferase Inhibitors Promote Homologous Recombination Deficiency through Induction of Immune Signaling, Sensitizing Acute Myeloid Leukemia Cells to PARP Inhibitors

Aksinija A Kogan, BS, MS, Lena J Mclaughlin, BS, Maria R. Baer, MD, Stephen Baylin, MD, Michael Topper, BS, Feyruz V. Rassool, BSc, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3763.
https://doi.org/10.1182/blood-2019-129535
Published: 2019
Journal Articles

Bromodomain and Extra Terminal Domain (BET) Inhibitors Sensitize Chronic Myelomonocytic Leukemia (CMML) to PIM Inhibition Via Downregulation of Mir-33a

Christopher Letson, BS, Alexis Vedder, BS, Ariel Quintana, PhD, Phillip Liu, PhD, Brett Reid, Maria E Balasis, Hannah Newman, BS, Traci Kruer, PhD, Luciana L Almada, PhD, Guolin Zhang, PhD, Martin Fernandez-Zapico, MD, Mrinal M Patnaik, MDMBBS, Jeffrey E. Lancet, MD, Rami S. Komrokji, MD, P.K. Epling-Burnette, PharmD, PhD, Alan F. List, MD, Eric B. Haura, MD, Gary W. Reuther, Thomas A. Sellers, PhD, Holly K. Koblish, PhD, Eric Padron, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4220.
https://doi.org/10.1182/blood-2019-128165
Published: 2019
Journal Articles

Targeting DNA Damage and Repair in Acute Myeloid Leukemia Carrying Internal Tandem Duplication of Fms-like Tyrosine Kinase 3 (FLT3-ITD) - a Mechanistic Study

Ka Lam Nelson Ng, PhD, Claire Lynn, Thomas Wing Yan Leung, Eric Chi Wai So, PhD, Anskar Yu Hung Leung, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1261.
https://doi.org/10.1182/blood-2019-129472
Published: 2019
Journal Articles

A Multi-Omic Precision Medicine Clinical Trial in Acute Leukemia

Pamela S. Becker, MD PhD, Vivian G. Oehler, MD, Carl Anthony Blau, MD, Timothy S Martins, PhD, Niall Curley, Sylvia Chien, Jin Dai, PhD, Nicole Kauer, Ka Yee Yeung, PhD, Ling-Hong Hung, PhD, Cody Hammer, Paul C. Hendrie, MD PhD, Mary-Elizabeth M. Percival, MD, Ryan D. Cassaday, MD, Bart L. Scott, MD, Roland B. Walter, MD PhD MS, Kelda Gardner, PA-C, Mary Gwin, Heather Smith, PA-C, Andrew Carson, PhD, Bradley Patay, MD, Elihu H. Estey, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1269.
https://doi.org/10.1182/blood-2019-130996
Published: 2019
Journal Articles

Saliva-Omics in Plasma Cell Disorders — Proof of Concept and Potential As a Non-Invasive Tool for Monitoring Disease Burden and MRD Status

Ciara Tierney, BSc, Despina Bazou, BSc, MSc, PhD, Giao Le, BA (Hons), MB BCh, MRCPI, Paul Dowling, BSc, PhD, Peter O'Gorman, MD PhD FRCP, FRCPath
Journal: Blood
Blood (2018) 132 (Supplement 1): 3177.
https://doi.org/10.1182/blood-2018-99-110166
Published: 2018
Journal Articles

The Inhibition of Platelets Restore Anti-Tumor Immune Response to Ovarian Cancer and Its Therapeutic Implication

Min Soon Cho, PhD, Omayra Gonzalez-Pagan, MD PhD, Karem Court Pinto, PhD, Anil Sood, MD, Vahid Afshar-Kharghan, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3698.
https://doi.org/10.1182/blood-2018-99-116530
Published: 2018
Journal Articles

Engineering of CD19-Specific Chimeric Antigen Receptor T Cells with the Integrin CD103 Results in Augmented Therapeutic Efficacy Against Human Lymphoma in a Preclinical Model

Hongxing Sun, PhD, Shan He, PhD, Lijun Meng, PhD, Ying Wang, PhD, Hanghang Zhang, PhD, Yongnian Liu, Jian Wang, MD, Min Tao, MD, Stefan Klaus Barta, MD MRCP, MS, Essel D. Al-Saleem, MD, Henry C. Fung, FRCP, MBBChir, Jean-Pierre Issa, MD, Leizhen Zheng, MD, Yi Zhang, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2050.
https://doi.org/10.1182/blood-2018-99-117354
Published: 2018
Journal Articles

iPSC-Derived NK Cells and Anti-PD-1 Antibody Synergize to Enhance T Cell Cytokine and Cytolytic Responses Against Multiple Tumors

Frank Cichocki, PhD, Ryan Bjordahl, PhD, Svetlana Gaidarova, MS, Sajid Mahmood, PhD, Paul Rogers, PhD, Moyar Q. Ge, PhD, Dan S Kaufman, MD PhD, Sarah Cooley, MD, Bahram Valamehr, PhD, Jeffrey S. Miller, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 730.
https://doi.org/10.1182/blood-2018-99-114893
Published: 2018
Journal Articles

Prognostic and Biologic Significance of Transfer RNA-Derived Small RNAs (tsRNAs) Expression in Younger Adult Patients (Pts) with Cytogenetically Normal Acute Myeloid Leukemia (CN-AML)

Marius Bill, MD PhD, Dario Veneziano, PhD, Jessica Kohlschmidt, PhD, Krzysztof Mrózek, MDPhD, Giovanni Nigita, PhD, Maria G. Krantz, Deedra Nicolet, MS, Dimitrios Papaioannou, MD, Allison Walker, Zachary Brannan, Bayard L. Powell, MD, Richard M. Stone, MD, Geoffrey L. Uy, MD, Jonathan E. Kolitz, MD, Eunice S. Wang, MD, Adrienne M. Dorrance, PhD, Carlo M. Croce, MD, Ramiro Garzon, MD, Clara D. Bloomfield, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 89.
https://doi.org/10.1182/blood-2018-99-115270
Published: 2018
Journal Articles

BRCA1 & BRCA2 Germline Variants Are Enriched in MDS/AML and Portend Higher Average Mutational Burden

Louis Williams, MD MBA, Teodora Kuzmanovic, BA, Cassandra M. Hirsch, Bartlomiej P. Przychodzen, Yogenthiran Saunthararajah, MD, Hassan Awada, MD, Vera Adema, PhD, Amy C Graham, BS, MS, Tomas Radivoyevitch, PhD, Hetty E. Carraway, MD MBA, Aziz Nazha, Mikkael A. Sekeres, MD MS, Jaroslaw P. Maciejewski
Journal: Blood
Blood (2018) 132 (Supplement 1): 4352.
https://doi.org/10.1182/blood-2018-99-116802
Published: 2018
Journal Articles

Clinical Response and Tolerability of Selinexor in Acute Myeloid Leukemia and Other Hematologic Malignancies - a Systematic Review

Muhammad Junaid Tariq, MD, Muhammad Yasir, MD, Amna Khalid, MD, Saher Nasir Amin, MD, Sharoon Samuel, MBBS, Muhammad Jahanzeb Khalil, MD, Shehroz Aslam, MD, Malik Qistas Ahmad, MD MBBS, Muhammad Asad Fraz, MD, Muhammad Usman, MD, Awais Ijaz, MD, Arafat Ali Farooqui, MBBS, Seren Durer, MD, Ceren Durer, MD, Faiz Anwer, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5231.
https://doi.org/10.1182/blood-2018-99-116819
Published: 2018
Journal Articles

Comprehensive Genomic Profiling of Angioimmunoblastic T-Cell Lymphoma (AITL) in Chinese Patients

Lihua Zhong, MD, Jianchao Wang, Yanping Chen, Weiqing Lin, Xiaoyan Liu, PhD, Ying Dou, Lihua Sun, Songhui Zhao, Xiaowei Dong, Utpal Dave, MD, Kai Wang, MD, Gang Chen
Journal: Blood
Blood (2018) 132 (Supplement 1): 5293.
https://doi.org/10.1182/blood-2018-99-119891
Published: 2018
Journal Articles

The Mantle Cell Lymphoma Response to VCR Protocol Associated with Its Sensitivity to Hypomethylation Regulation-a Collateral Study on VCR Phase I Trial

Jeffrey J Pu, MD PhD, Matthew Nemesure, W. Christopher Ehmann, MD, David F Claxton, MD, Joseph J Drabick, MD, Anna C Salzberg, Yuka I Kawasawa, PhD, Elliot Epner, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5295.
https://doi.org/10.1182/blood-2018-99-118192
Published: 2018